J, Z., XT, L., HQ, Y., L, F., D, W., YD, L., . . . CM, X. (2023). Author Correction: Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. Experimental & molecular medicine, 55(10), 2281. https://doi.org/10.1038/s12276-023-01116-8
Chicago Style (17th ed.) CitationJ, Zhang, Lin XT, Yu HQ, Fang L, Wu D, Luo YD, Zhang YJ, and Xie CM. "Author Correction: Elevated FBXL6 Expression in Hepatocytes Activates VRK2-transketolase-ROS-mTOR-mediated Immune Evasion and Liver Cancer Metastasis in Mice." Experimental & Molecular Medicine 55, no. 10 (2023): 2281. https://doi.org/10.1038/s12276-023-01116-8.
MLA (9th ed.) CitationJ, Zhang, et al. "Author Correction: Elevated FBXL6 Expression in Hepatocytes Activates VRK2-transketolase-ROS-mTOR-mediated Immune Evasion and Liver Cancer Metastasis in Mice." Experimental & Molecular Medicine, vol. 55, no. 10, 2023, p. 2281, https://doi.org/10.1038/s12276-023-01116-8.